- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2009 (2009), Article ID 827562, 9 pages
DNA Damage/Repair and Polymorphism of the hOGG1 Gene in Lymphocytes of AMD Patients
1Department of Molecular Genetics, University of Lodz, 90-237 Lodz, Poland
2Department of Ophthalmology, Medical University of Warsaw, 03-709 Warsaw, Poland
Received 26 March 2009; Revised 25 June 2009; Accepted 24 August 2009
Academic Editor: Hatem El-Shanti
Copyright © 2009 Katarzyna Wozniak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Oxidative stress is thought to play a role in the pathogenesis of age-related macular degeneration (AMD). We determined the extent of oxidative DNA damage and the kinetics of its removal as well as the genotypes of the Ser326Cys polymorphism of the hOGG1 gene in lymphocytes of 30 wet AMD patients and 30 controls. Oxidative DNA damage induced by hydrogen peroxide and its repair were evaluated by the comet assay and DNA repair enzymes. We observed a higher extent of endogenous oxidative DNA damage and a lower efficacy of its repair in AMD patients as compared with the controls. We did not find any correlation between the extent of DNA damage and efficacy of DNA repair with genotypes of the Ser326Cys polymorphism. The results obtained suggest that oxidative DNA damage and inefficient DNA repair can be associated with AMD and the variability of the hOOG1 gene may not contribute to this association.
Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness in Western countries among people aged 50 years and older . The prevalence of AMD in various European countries (Norway, Estonia, United Kingdom, France, Italy, Greece, and Spain) was 3.32% with the of geographic atrophic AMD of 1.2%, neovascular AMD 2.3% and bilateral AMD 1.4% . AMD is also a significant health problem in the United States, with a current estimate of about 1.75 million persons with advanced AMD in the general population and about 7.3 million people with early stages of AMD defined by large retinal drusen. It has been projected that by the year 2020, approximately about 2.95 million people will have advanced AMD and an additional 6.4 million white individuals will have the early stages of AMD in at least one eye . AMD prevalence has been rising across the globe. As the average life span of humans continues to increase, especially in the developed countries, the incidence of AMD is expected to nearly double within the next 25 years.
The aetiology of AMD remains elusive because it is a multifactorial disease in which both genetic and environmental factors have been implicated. To date, age, smoking, exposure to light, and diet have been successfully identified [4, 5]. Various studies have indicated a significant genetic contribution to AMD, including those reported a higher occurrence of AMD among monozygotic twins and first-degree relatives than spouses and unrelated individuals . AMD was also associated with several DNA single nucleotide polymorphisms (SNPs) [7–9].
Oxidative stress has been implicated in the pathogenesis of AMD. The retinal pigment epithelium (RPE) cells function in an environment that is rich in endogenous reactive oxygen species (ROS). The activity of RPE cells, the high local oxygen concentration, and the chronic exposure to light contribute to the production of ROS [10–13]. Although multiple physiologic mechanisms protect the RPE from the toxic effects of light and oxidative damage, mounting evidence suggests that chronic exposure to oxidative stress over the long term may damage the RPE and predispose it to the development of AMD. Supporting this theory is the observation that large drusen, which are deposited under the RPE in patients with macular degeneration, consist of insoluble aggregates of oxidized lipids and proteins derived from the photochemical reactions of visual transduction [14, 15].
In the present paper we checked the correlation between the level of DNA damage measured with the alkaline comet assay and the kinetics of removal of DNA damage induced by hydrogen peroxide in peripheral blood lymphocytes of patients with wet form of AMD and individuals without visual disturbances. Most oxidative damage associated with AMD will occur within postmitotic cells of the retina and will be environmental in origin. We chose peripheral blood lymphocytes as they would be affected by the environmental condition causing oxidative DNA damage in the retina. Moreover, they could provide evidence on inherited defect in DNA damage/repair, which would be enhanced by oxidative stress. Furthermore, metabolic disturbances associated with AMD may affect whole organism . We also correlated the metrics of DNA damage and repair with the genotype of the hOGG1 gene polymorphism: a transversion at 1245 position producing a substitution at the codon 326 (the Ser326Cys polymorphism). We chose the hOGG1 gene due to its central role in the repair of oxidatively damaged DNA. To evaluate the extent of DNA damage, the efficacy of DNA repair and the sensitivity to exogenous mutagens in AMD patients we determined (1) the level of DNA damage measured by alkaline comet assay and oxidative DNA damage and (2) the capacity to remove DNA damage induced by hydrogen peroxide in the peripheral blood lymphocytes of AMD patients and healthy individuals. DNA damage and repair were evaluated by alkaline single cell gel electrophoresis (comet assay). Hydrogen peroxide is a standard agent to induce oxidative DNA damage. In order to assess the role of oxidative DNA damage in AMD patients, we employed two DNA repair enzymes: endonuclease III (Nth) and formamidopyrimidine-DNA glycosylase (Fpg), preferentially recognizing oxidized DNA bases. Nth converts oxidized pyrimidines into strand breaks, which can be detected by the comet assay . Fpg is a glycosylase initiating base excision repair in E. coli. It recognizes and removes 7,8-dihydro-8-oxoguanine (8-oxoguanine), the imidazole ring-opened purines, 2,6-diamino-4-hydroxy-5-formamidopyrimidine (Fapy-Gua), and 4,6-diamino-5-formamido-pyrimidine (Fapy-Ade) as well as small amounts of 7,8-dihydro-8-oxoadenine (8-oxoadenine) . The removing of specific modified bases from DNA by this enzyme leads to apurinic or apirymidinic sites, which are subsequently cleaved by its AP-lyase activity, giving a gap in the DNA strand, which can be detected by the comet assay .
2. Materials and Methods
Blood samples were obtained from patients with wet form of AMD () and healthy sex- and age-matched individuals (). Medical history was obtained from all subjects. The patients underwent ophthalmic examination including best-corrected visual acuity, intraocular pressure, slit-lamp examination, and fundus examination using noncontact and contact fundus lenses with a slit lamp. Diagnosis of wet form AMD was confirmed by optical coherence tomography (OCT), fluorescein angiography (FA), and in some cases indocyanin green angiography (ICG). OCT evaluated retinal thickness, the presence of subretinal fluid and intraretinal oedema; angiography assessed the anatomical status of the retinal vessels, the presence of choroidal neovascularisaton (CNV) and leakage.
The OCT examinations were performed with Stratus OCT model 3000, software version 4.0. The FA and ICG examinations were completed with a Topcon TRC-50I IX fundus camera with the digital Image Net image system (ver. 2.14; Topcon Co., Tokyo, Japan).
The Local Ethic Committee approved the study and each patient gave a written consent. Neither patients nor controls reported cancer, diabetes, or other disease known or suspected to affect DNA repair.
2.2. Cell Preparation
Blood samples were immediately transported to the laboratory on ice. Peripheral blood lymphocytes (PBL) were isolated by centrifugation in a density gradient of histopaque-1077 (15 minutes, 280 g, 4°C) and suspended in RPMI 1640 medium at cells per mL.
2.3. Comet Assay
The comet assay was performed at pH 13 essentially according to the procedure of Singh et al.  with modifications [16, 18] as described previously . A freshly prepared suspension of the cells in 0.75% LMP agarose dissolved in PBS was spread onto microscope slides precoated with 0.5% NMP agarose. The cells were then lysed for 1 hour at 4°C in a buffer consisting of 2.5 M NaCl, 100 mM EDTA, 1% Triton X-100, 10 mM Tris, pH 10. After the lysis, the slides were placed in an electrophoresis unit, DNA was allowed to unwind for 20 minutes in the electrophoresis solution consisting of 300 mM NaOH and 1 mM EDTA, pH 13. Electrophoresis was conducted at ambient temperature of 4°C (the temperature of the running buffer did not exceed 12°C) for 20 minutes at an electric field strength of 0.73 V/cm (28 mA). The slides were then washed in water, drained and stained with 2 g/mL DAPI, and covered with cover slips. To prevent additional DNA damage, all the steps described above were conducted under dimmed light or in the dark.
The comets were observed at 200 × magnification in an Eclipse fluorescence microscope (Nikon, Tokyo, Japan) attached to COHU 4910 video camera (Cohu, San Diego, CA, USA) equipped with a UV-1 filter block (an excitation filter of 359 nm and a barrier filter of 461 nm) and connected to a personal computer-based image analysis system Lucia-Comet v. 4.51 (Laboratory Imaging, Praha, Czech Republic). One hundred images were randomly selected from each sample and the percentage of DNA in the tail of comets was measured. All the values in this study were expressed as mean ± S.E.M.
2.4. DNA Damage and Repair
Hydrogen peroxide was added to the suspension of the cells to give a final concentration of 10 M. Lymphocytes were incubated with hydrogen peroxide for 10 minutes at 4°C. The cells after treatment were washed and resuspended in RPMI 1640 medium. A freshly prepared suspension of the cells in LMP agarose dissolved in PBS was spread onto microscope slides. The slides were processed as described in the Section 2.3.
To examine DNA repair, the cells, after treatment with hydrogen peroxide, were washed and resuspended in a fresh, RPMI 1640 medium preheated to 37°C. Aliquots of the cell suspension were taken immediately “time zero” and at 120 minutes later. Placing the samples in an ice bath stopped DNA repair. The slides were processed as described in the Section 2.3.
We considered a relative difference between the extents of DNA damage at “time zero” and 120 minutes as a measure of the efficacy of DNA repair.
2.5. DNA Repair Enzymes Treatment
A freshly prepared suspension of the cells in LMP agarose dissolved in PBS was spread onto microscope slides. The slides after cell lysis were washed three times (5 minutes, 4°C) in an enzyme buffer containing 40 mM HEPES-KOH, 0.1 M KCl, 0.5 mM EDTA, 0.2 mg/mL bovine serum albumin, pH 8.0. The slides were then drained and incubated for 30 minutes at 37°C with 0.03 g of Nth or Fpg in this buffer [16, 18]. The control received only the buffer. The slides were processed as described in the Section 2.3. Each value of oxidative DNA modification recognized by these enzymes derives a mean difference between Fpg/Nth-treated and nontreated control from 30 patients with AMD and 30 healthy controls. To check the ability of the enzymes to recognize oxidized DNA bases in our experimental conditions, the cells were incubated with hydrogen peroxide, lysed, and posttreated with Fpg or Nth.
2.6. Genotype Determination
Genomic DNA was prepared from peripheral blood of AMD patients and healthy individuals by using of commercial Blood Mini Kit (AKOR Laboratories, Gdansk, Poland). The genotypes of the Ser326Cys polymorphism of the hOOG1 gene were determined with the following primers: sense -GTTTTCACTAATGAGCTTGC-, antisense -AGTGGTATAATCATGTGGGT-. The 200 bp PCR product was digested overnight with 5 U of the restriction enzyme SatI (Fermentas, Vilnius, Lithuania). The Cys allele was digested into 100 bp fragments, whereas the Ser variant remained intact. The PCR products were run on 2.5% agarose gel.
2.7. Data Analysis
The values of the comet assay in this study were expressed as mean ± S.E.M. from two experiments, that is, data from two experiments, 100 measurements each, were pooled and the statistical parameters were calculated. If no significant differences between variations were found, as assessed by Snedecor-Fisher test, the differences between means were evaluated by applying the Student’s t test. Otherwise, the Cochran-Cox test was used. Relative difference between extents of DNA damage in time zero and 120 minutes expressed in percentage was used as a measure of the efficacy of DNA repair after treatment with hydrogen peroxide. Distribution of genotypes and alleles between groups was analysed using the χ2-test. Relationship between genotype and cancer was assessed by the logistic regression. The data were analysed using Statistica package (StatSoft, Tulsa, OK, USA).
3.1. DNA Damage
The mean extent of endogenous DNA damage measured as the percentage of DNA in comet tail of lymphocytes of AMD patients and controls is displayed in Figure 1. We observed a higher level of endogenous DNA damage in AMD patients than in the controls ().
3.2. Endogenous Oxidative DNA Damage
Figure 2 presents the mean DNA damage measured as percentage tail DNA of lymphocytes from AMD patients and healthy individuals, lysed and posttreated with Nth (Figure 2(a)) or Fpg (Figure 2(b)). Subtracting the values for an enzyme-specific buffer only treatment normalized these results. Therefore, the results indicate solely the DNA base-modification, which are not alkali-labile. There were significant differences () between the mean extent of oxidative DNA damage recognized by Nth between AMD patients and controls (Figure 2(a)). There were no significant differences () between the mean extent of oxidative DNA damage recognized by Fpg between AMD patients and controls (Figure 2(b)).
Because high level of oxidative DNA damage may be associated with an impaired DNA repair, individuals with the extent of oxidative DNA damage higher than the mean for respective group were selected for further genotype analysis.
3.3. DNA Repair
The mean percentage tail DNA of lymphocytes from AMD patients and controls exposed for 10 minutes to 10 μM hydrogen peroxide immediately after the exposure as well as 120 minutes thereafter is presented in Table 1 along with the efficacy of DNA repair. The “minus” sign indicates that the extent of DNA damage at 120 minutes was greater than at the zero time. The efficacy of DNA repair in AMD patients was significantly () lower than that observed in the controls. Moreover, the extent of initial DNA damage after hydrogen peroxide treatment was significantly higher in AMD group than in the control (). We assumed that inefficient DNA repair occurred when we did not observe significant decrease in DNA damage after 120 minutes of repair incubation. We did not observe any difference in the mean efficacy of DNA repair between AMD patients (21 subjects with inefficient DNA repair) and control group (17 subjects with inefficient DNA repair). However, the data show that all control samples showed decrease in DNA damage after 120 minutes. 43% of the AMD patients (13 persons) show a further increase in DNA damage at 120 minutes. These results suggest that the efficacy of the repair of oxidative DNA damage in AMD patients was lower than in the controls. We observed considerable differences in the efficacy of DNA repair between individuals enrolled in the study, especially in AMD patients. We speculate that it could be linked with different activity of allelic variants of genes involved in the repair of oxidative DNA lesions. To verify this hypothesis, we selected only individuals with inefficient DNA repair (Table 1) for further genotype analysis.
3.4. Genotype Analysis
There were no significant differences between the distributions of genotypes of the Ser326Cys polymorphism of the hOGG1 gene and the frequency of the Ser and Cys alleles for AMD patients and controls with high level of endogenous oxidative DNA damage (Table 2). There also were no significant differences between the distributions of the genotypes and frequencies of the alleles of the Ser326Cys polymorphism for AMD patients and controls with impaired DNA repair after hydrogen peroxide treatment (Table 3).
Oxidative damage to RPE cells and photoreceptors has been implicated in the pathogenesis of AMD. This kind of cellular stress induces various types of DNA damage, like base modifications, DNA breaks, and alkali-labile sites. They are mainly removed by base excision repair (BER) pathway. BER removes modified base by specific glycosylases, which can be assisted by endonucleases. The next steps are abasic site priming, gap filling, and ligation. 8-Hydroxydeoxyguanosine (8-OH-Gua) glycosylase 1 (hOGG1) is the primary enzyme for the repair of 8-OH-Gua in human cells . The presence of 8-OH-Gua residues in DNA leads to a GC→TA transversion, unless it is repaired before DNA replication. For this reason, the presence of 8-OH-Gua in DNA may lead to mutagenesis and the level of 8-OH-Gua is commonly used as a biomarker of oxidative DNA damage .
A growing body of evidence suggests that mitochondrial dysfunction may be associated with AMD and proposes a specific pathophysiological mechanisms involving mtDNA oxidative damage, altered mitochondrial translation, import of nuclear-encoded proteins and ATP synthase activity as an explanation of this association [23–25]. Unfortunately, data on the involvement of DNA repair in AMD pathogenesis are scare. There are a few reports focusing on the mitochondrial DNA. These reports suggest increased mitochondrial DNA damage and downregulation of mitochondrial DNA repair in RPE cells and choroid. An increased level of 8-OHdG and downregulation of base excision glycosylases in aged rodent RPE and choroid as compared with young controls was also reported . The recent data indicate also that the altered function of the putative mitochondrial protein LOC387715/ARMS2 by a 69A>S substitution strongly enhances the susceptibility to aging-associated degeneration of macular photoreceptors .
The number of patients we analyzed may not seem to be impressive as compared with epidemiological studies assessing a risk linked with particular genotype/phenotype. The primary goal of our study was to search for a correlation between genotype and phenotype, although we calculated the odds ratio, because it is a standard procedure in polymorphism study. Such studies with comet assay are typically performed on a population of several dozen individuals and very exceptionally this number exceeds one hundred.
Although oxidative stress is usually linked with the dry AMD and so are the disturbances in the DNA repair machinery, our results suggest extending this point of view to wet AMD. They may also suggest a closer association between the two forms of the disease.
Our study was performed on peripheral blood lymphocytes. They should have been performed on the retina cells, but these cannot be obtained from live AMD patients as easily as the lymphocytes. Lymphocytes are easily accessible and their genetic constitution with the regards of DNA repair processes reflects that of the retina cells. There is no doubt that AMD is not only an ocular disease. However, we found a decreased efficacy of DNA repair in peripheral blood lymphocytes of AMD patients, but we do not have any solid evidence that this effect was a consequence of AMD. This is rather an open question. We hypothesize that AMD may be a result of a decreased capability of every cell of an organism to repair DNA damage and increased exposure of ocular cells to etiological agents, like UV radiation, inducing DNA damage in these cells. On the other hand, we cannot exclude the possibility that the observed decrease in the efficacy of DNA repair may be a consequence of general metabolic disturbance associated with AMD. We think that the results we obtained suggest that there may be an interplay between disturbances in the general state of an organism, manifested by decreased efficacy of DNA repair and local (ocular) changes evoked by genetic and environmental factors.
We used the comet assay to study DNA damage and repair. This technique is a versatile and sensitive method for measuring DNA damage such as single- and double-strand breaks as well as alkali-labile sites in DNA. It is a valuable tool in population monitoring, for example, in assessing the role of oxidative stress in human disease and in monitoring the effects of dietary antioxidants. A simple modification allows the measurement of DNA repair. In combination with the analysis of polymorphisms in relevant genes, comet assay may provide important information on the interaction between genetic variation and environmental factors in the maintaining genome stability .
Although the increase in the tail DNA in AMD patients as compared with the controls was statistically significant it should not be a priori considered as biologically or medically relevant. However, because AMD may be considered as a multifactorial disease, this increase may significantly contribute to the disease.
The efficacy of DNA repair may be affected by variation in DNA repair genes. Several types of genetic polymorphisms can be found within the human genome, such as repeat polymorphisms, insertions, and deletions. However, most DNA sequences variation in human populations is in the form of SNPs . SNPs can be defined as persistent substitutions of a single base with a frequency of more than 1% in at least one population. Recently, it has been demonstrated the potential role of SNPs in AMD and other age-related diseases . Three SNPs in the MnSOD, MEHE, and Paraoxonase genes related to oxidative stress have previously been reported in association with AMD in Japanese populations [30, 31].
It seems that the hOGG1 gene is a good candidate to study DNA repair genes, which can be associated with AMD. This gene is expressed in multiple alternatively spliced isoforms and is highly polymorphic . OGG1-type 1a of hOGG1 gene is constitutively expressed in cancerous and noncancerous human cells as nuclear form of protein . The protein level of hOGG1 decreases in aged RPE and choroids cells . A C → G transversion at 1245 position in the exon 7 of the hOGG1 gene results in an amino acid substitution from serine to cysteine in the codon 326. There are contradictory results of studies on the role of this polymorphism in the catalytic activity of hOGG1 protein, but it was shown that the Ser326 allele exhibited higher enzymatic activity than the Cys326 variant in an in vitro E. coli complementation assay . Several studies have suggested that Cys326 type allele may be associated with the increased risk for esophageal , otolaryngeal , lung , stomach , and prostate cancers .
In our studies we did not find significant differences between the distributions of Ser326Cys polymorphism of hOGG1 gene and the frequency of the Ser and Cys alleles for AMD patients and controls with high level of endogenous oxidative DNA damage and impaired DNA repair after hydrogen peroxide treatment. This is not surprising due to a limited number of patients enrolled in our study and a high variability in the DNA repair rate between them. A lack of association between the Ser326Cys polymorphism and AMD was also demonstrated in other research . However, further studies are needed to confirm the lack of association between the Ser326Cys polymorphism and AMD.
Genetic variability of the genes involved in the expression of the hOGG1 gene may also contribute to the efficacy of DNA repair. The Cockayne syndrome B (CSB) gene, also called ERCC6, collaborates with hOGG1 to carry out preferential DNA repair in eukaryotes [41, 42]. This gene also plays a role in the maintenance of an efficient expression of the hOGG1 gene. It was shown that the G allele of the C-6530C polymorphism of the ERCC6 gene could be associated with a risk of AMD development and possibly interacted with an SNP in the CFH gene (complement factor H gene) to influence AMD susceptibility . Recently, several studies have also shown a strong association of CFH SNPs with AMD [43–45]. It was revealed that ERCC6 C-6530G, which is located in the regulatory region of the gene, upregulated the transcript and protein expression. These data support the hypothesis that DNA repair mechanisms may play a role in AMD pathogenesis.
Our results suggest that endogenous oxidative DNA damage and low efficacy of DNA repair can be associated with the occurrence of AMD in wet form. High level of oxidative DNA damage and impaired repair of such damage may not be associated with the variants of the Ser326Cys polymorphism of the hOGG1 gene.
This work was supported by the Grant no. 402 071 32/2210 of Ministry of Science and Higher Education. The authors would like to thank Aleksandra Malinowska, Anna Krzyzanowska, and Monika Kicinska for technical assistance.
- S. L. Fine, J. W. Berger, A. M. Maguire, and A. C. Ho, “Age-related macular degeneration,” The New England Journal of Medicine, vol. 342, no. 7, pp. 483–492, 2000.
- C. A. Augood, J. R. Vingerling, P. T. de Jong, et al., “Prevalence of age-related maculopathy in older europeans: the European Eye Study (EUREYE),” Archives of Ophthalmology, vol. 124, no. 4, pp. 529–535, 2006.
- D. S. Friedman, B. J. O'Colmain, B. Muñoz, et al., “Prevalence of age-related macular degeneration in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 564–572, 2004.
- Age-Related Eye Disease Study Research Group, “A randomised, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8,” Archives of Ophthalmology, vol. 119, pp. 1417–1436, 2001.
- L. Hyman and R. Neborsky, “Risk factors for age-related macular degeneration: an update,” Current Opinion in Ophthalmology, vol. 13, no. 3, pp. 171–175, 2002.
- J. M. Seddon, J. Cote, W. F. Page, S. H. Aggen, and M. C. Neale, “The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences,” Archives of Ophthalmology, vol. 123, no. 3, pp. 321–327, 2005.
- J. Tuo, B. Ning, C. M. Bojanowski, et al., “Synergic effects of polymorphisms in ERCC6 5′ flanking region and complement factor H on age-related macular degeneration predisposition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9256–92561, 2006.
- B. J. Wegscheider, M. Weger, W. Renner, et al., “Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration,” Ophthalmology, vol. 114, no. 4, pp. 738–742, 2007.
- J. M. Seddon, P. J. Francis, S. George, D. W. Schultz, B. Rosner, and M. L. Klein, “Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration,” The Journal of the American Medical Association, vol. 297, no. 16, pp. 1793–1800, 2007.
- C. K. Dorey, G. G. Khouri, L. A. Syniuta, S. A. Curran, and J. J. Weiter, “Superoxide production by porcine retinal pigment epithelium in vitro,” Investigative Ophthalmology & Visual Science, vol. 30, no. 6, pp. 1047–1054, 1989.
- M. V. Miceli, M. R. Liles, and D. A. Newsome, “Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis,” Experimental Cell Research, vol. 214, no. 1, pp. 242–249, 1994.
- B. S. Winkler, M. E. Boulton, J. D. Gottsch, and P. Sternberg, “Oxidative damage and age-related macular degeneration,” Molecular Vision, vol. 5, pp. 32–42, 1999.
- S. Beatty, H. H. Koh, M. Phil, D. Henson, and M. Boulton, “The role of oxidative stress in the pathogenesis of age-related macular degeneration,” Survey of Ophthalmology, vol. 45, no. 2, pp. 115–134, 2000.
- J. W. Crabb, M. Miyagi, X. Gu, et al., “Drusen proteome analysis: an approach to the etiology of age-related macular degeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 23, pp. 14682–14687, 2002.
- A. Hanneken, F. F. Lin, J. Johnson, and P. Maher, “Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death,” Investigative Ophthalmology & Visual Science, vol. 47, no. 7, pp. 3164–3177, 2006.
- A. R. Collins, S. J. Duthie, and V. L. Dobson, “Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA,” Carcinogenesis, vol. 14, no. 9, pp. 1733–1735, 1993.
- H. E. Krokan, R. Standal, and G. Slupphaug, “DNA glycosylases in the base excision repair,” The Biochemical Journal, vol. 325, no. 1, pp. 1–16, 1997.
- M. D. Evans, I. D. Podmore, G. J. Daly, D. Perrett, J. Lunec, and K. E. Herbert, “Detection of purine lesions in cellular DNA using single cell gel electrophoresis with Fpg protein,” Biochemical Society Transactions, vol. 23, no. 3, p. 434S, 1995.
- N. P. Singh, M. T. McCoy, R. R. Tice, and E. L. Schneider, “A simple technique for quantitation of low levels of DNA damage in individual cells,” Experimental Cell Research, vol. 175, no. 1, pp. 184–192, 1988.
- J. Blasiak and J. Kowalik, “A comparison of the in vitro genotoxicity of tri- and hexavalent chromium,” Mutation Research, vol. 469, no. 1, pp. 135–145, 2000.
- N. Yang, M. A. Chaudhry, and S. S. Wallace, “Base excision repair by hNTH1 and hOGG1: a two edged sword in the processing of DNA damage in -irradiated human cells,” DNA Repair, vol. 5, no. 1, pp. 43–51, 2006.
- S. Boiteux and J. P. Radicella, “The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis,” Archives of Biochemistry and Biophysics, vol. 377, no. 1, pp. 1–8, 2000.
- A. L. Wang, T. J. Lukas, M. Yuan, and A. H. Neufeld, “Increased mitochondrial DNA damage and down-regulation of DNA repair enzymes in aged rodent retinal pigment epithelium and choroid,” Molecular Vision, vol. 14, pp. 644–651, 2008.
- F. Q. Liang and B. F. Godley, “Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration,” Experimental Eye Research, vol. 76, no. 4, pp. 397–403, 2003.
- C. L. Nordgaard, P. P. Karunadharma, X. Feng, T. W. Olsen, and D. A. Ferrington, “Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration,” Investigative Ophthalmology & Visual Science, vol. 49, no. 7, pp. 2848–2855, 2008.
- A. Kanda, W. Chen, M. Othman, et al., “A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 41, pp. 16227–16232, 2007.
- A. R. Collins, “Investigating oxidative DNA damage and its repair using the comet assay,” Mutation Research, vol. 681, no. 1, pp. 24–32, 2007.
- M. Cargill and G. Q. Daley, “Mining for SNPs: putting the common variants-common disease hypothesis to the test,” Pharmacogenomics, vol. 1, no. 1, pp. 27–37, 2000.
- C. C. Klaver and R. Allikmets, “Genetics of macular dystrophies and implications for age-related macular degeneration,” Developments in Ophthalmology, vol. 37, pp. 155–169, 2003.
- K. Kimura, Y. Isashiki, S. Sonoda, T. Kakiuchi-Matsumoto, and N. Ohba, “Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration,” American Journal of Ophthalmology, vol. 130, no. 6, pp. 769–773, 2000.
- T. Ikeda, H. Obayashi, G. Hasegawa, et al., “Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration,” American Journal of Ophthalmology, vol. 132, no. 2, pp. 191–195, 2001.
- K. Nishioka, T. Ohtsubo, H. Oda, et al., “Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced hOGG1 mRNAs,” Molecular Biology of the Cell, vol. 10, no. 5, pp. 1637–1652, 1999.
- K. Shinmura, T. Kohno, M. Takeuchi-Sasaki, et al., “Expression of the OGG1-type 1a (nuclear form) protein in cancerous and non-cancerous human cells,” International Journal of Oncology, vol. 16, no. 4, pp. 701–707, 2000.
- C. Dherin, J. P. Radicella, M. Dizdaroglu, and S. Boiteux, “Excision of oxidatively damaged DNA bases by the human -hOGG1 protein and the polymorphic -hOGG1(Ser326Cys) protein which is frequently found in human populations,” Nucleic Acids Research, vol. 27, no. 20, pp. 4001–4007, 1999.
- D.-Y. Xing, W. Tan, N. Song, and D. X. Lin, “Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a chinese population,” International Journal of Cancer, vol. 95, no. 3, pp. 140–143, 2001.
- A. Elahi, Z. Zheng, J. Park, K. Eyrng, T. McCaffrey, and P. Lazarus, “The human hOGG1 DNA repair enzyme and its association with otolaryngeal cancer risk,” Carcinogenesis, vol. 23, no. 7, pp. 1229–1234, 2002.
- L. Le Marchand, T. Donlon, A. Lum-Jones, A. Seifried, and L. R. Wilkens, “Association of the hOOG1 Ser326Cys polymorphism with lung cancer risk,” Cancer Epidemiology, Biomarkers & Prevention, vol. 11, no. 4, pp. 409–412, 2002.
- T. Takezaki, C. M. Gao, J. Z. Wu, et al., “hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese,” International Journal of Cancer, vol. 99, no. 4, pp. 624–627, 2002.
- L. Chen, A. Elahi, J. Pow-Sang, P. Lazarus, and J. Park, “Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer,” The Journal of Urology, vol. 170, no. 6, part 1, pp. 2471–2474, 2003.
- C. M. Bojanowski, J. Tuo, E. Y. Chew, K. G. Csaky, and C. C. Chan, “Analysis of Hemicentin-1, HOGG1, and E-selectin single nucleotide polymorphisms in age-related macular degeneration,” Transactions of the American Ophthalmological Society, vol. 103, pp. 37–45, 2005.
- J. Tuo, C. Chen, X. Zeng, M. Christiansen, and V. A. Bohr, “Functional crosstalk between hOGG1 and the helicase domain of Cockayne syndrome group B protein,” DNA Repair, vol. 1, no. 11, pp. 913–927, 2002.
- J. Tuo, P. Jaruga, H. Rodriguez, M. Dizdaroglu, and V. A. Bohr, “The cockayne syndrome group B gene product is involved in cellular repair of 8-hydroxyadenine in DNA,” The Journal of Biological Chemistry, vol. 277, no. 34, pp. 30832–30837, 2002.
- Y. P. Conley, A. Thalamuthu, J. Jakobsdottir, et al., “Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy,” Human Molecular Genetics, vol. 14, no. 14, pp. 1991–2002, 2005.
- A. O. Edwards, R. Ritter III, K. J. Abel, A. Manning, C. Panhuysen, and L. A. Farrer, “Complement factor H polymorphism and age-related macular degeneration,” Science, vol. 308, no. 5720, pp. 421–424, 2005.
- S. Zareparsi, K. E. H. Branham, M. Li, et al., “Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration,” American Journal of Human Genetics, vol. 77, no. 1, pp. 149–153, 2005.